BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22057283)

  • 1. Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease.
    Park JJ; Cheon JH; Hong SP; Kim TI; Kim WH
    Dig Dis Sci; 2012 Jan; 57(1):133-41. PubMed ID: 22057283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
    Boyle BM; Kappelman MD; Colletti RB; Baldassano RN; Milov DE; Crandall WV
    World J Gastroenterol; 2014 Jul; 20(27):9185-90. PubMed ID: 25083093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
    Kennedy NA; Kalla R; Warner B; Gambles CJ; Musy R; Reynolds S; Dattani R; Nayee H; Felwick R; Harris R; Marriott S; Senanayake SM; Lamb CA; Al-Hilou H; Gaya DR; Irving PM; Mansfield J; Parkes M; Ahmad T; Cummings JR; Arnott ID; Satsangi J; Lobo AJ; Smith M; Lindsay JO; Lees CW
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1313-23. PubMed ID: 25284134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease.
    Luber RP; Dawson L; Munari S; Kariyawasam VC; Martin C; Gibson PR; Sparrow MP; Ward MG
    J Gastroenterol Hepatol; 2021 Apr; 36(4):990-998. PubMed ID: 32881046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
    Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
    Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
    Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
    Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
    Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
    Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
    Lémann M; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Modigliani R; Bouhnik Y;
    Gastroenterology; 2005 Jun; 128(7):1812-8. PubMed ID: 15940616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.